Zaiton Binti Jamaluddin

Independent, Non-Executive Director


62 years




  • Master of Business Administration, Keele University, United Kingdom
  • Bachelor of Pharmacy, Western Australia Institute of Technology, Australia
  • Diploma in Management, Malaysian Institute of Management, Malaysia

Position on the Board

Independent, Non-Executive Director

Working Experience and Occupation

Zaiton has over 20 years of experience in the healthcare and pharmaceutical industry, beginning her illustrious career in 1982 as a pupil pharmacist with the Ministry of Health. Two years later, she joined the sales and marketing team of United Italian Trading Corporation. She then moved to Novo Industri A/S in 1985, where she served as the Assistant Medical Information Manager for the South East Asia Regional Office. In 1989, when Novo Industri A/S and Nordisk Gentofte A/S merged to become Novo Nordisk A/S, the world’s leading producer of insulin, Zaiton was appointed as its Business Development Manager for Malaysia, a post she held until 1993. From 1993 to 1997, she led Novo Nordisk’s Malaysian operations as its Country Manager. This was followed by a 10-year stint as General Manager of Novo Nordisk Pharma (M) Sdn Bhd. During this time, Zaiton helped to establish and grow Novo Nordisk’s business, mainly in insulin and oral diabetes care, haematology and women’s therapy.

She held roles in the areas of general management, sales and marketing, business development and training. In addition, she was involved in lobbying and making presentations to the government. An expert in her field, Zaiton has been a regular speaker on scientific as well as motivational topics. She was a member of the MARA Council from 2000 to 2002, a director of Malaysian Biotechnology Corporation Sdn Bhd from 2006 to 2008, and a former President of the Pharmaceutical Association of Malaysia from 2005 to 2007.

Zaiton is a member of the Institute of Corporate Directors Malaysia (ICDM).

Membership of Board Committees

  • Member, Audit Committee
  • Member, Risk Management Committee

Directorships of Other Public Companies

  • None